Cytokine control of developmental programs in normal hematopoiesis and leukemia.
about
The role of suppressors of cytokine signalling in human neoplasmsComplementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesisExpression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7,12-dimethylbenz(a)anthracene (DMBA) treated miceInhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like disease.Suppressors of cytokine signalling: SOCS.Hematological parameters, and hematopoietic growth factors: EPO and IL-3 in response to whole-body cryostimulation (WBC) in military academy students.Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes.Leukemia cells and the cytokine network: therapeutic prospects.Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.Regulation of haematopoiesis by growth factors - emerging insights and therapies.Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.Activation of the Jak3 pathway and myeloid differentiation.Cytokines in the differentiation therapy of leukemia: from laboratory investigations to clinical applications.T-cell development, doing it in a dish.Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.Induction in myeloid leukemic cells of genes that are expressed in different normal tissuesRed blood cells from pluripotent stem cells for use in transfusion.Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors.The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages.GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling.Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells.Radiation-induced bone marrow apoptosis, inflammatory bystander-type signaling and tissue cytotoxicity.CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative Patients.Clinical implications of SOCS1 methylation in myelodysplastic syndrome.A model of hematopoietic bone marrow apoptosis during growth factor deprivation in combination with a cytokine.
P2860
Q27026783-AC2A325D-6804-44A0-A989-7D1146F486E9Q33194891-891D5601-C749-4F92-9FBA-4351AFAB7FAAQ33636086-F5A698E3-624A-44AC-88AE-B98BC04FCB10Q33787781-4F0046BD-6F99-48B7-BA31-6B57C296DE0EQ33936687-A8977785-E134-44A9-B4C6-2F780F0F3C30Q34390794-31DF35D0-43E0-4861-A262-3A1DF58C17E4Q35083585-C3773E6C-1B9F-44CF-A123-6F46264B4F2AQ35088551-E10A396F-84EC-4938-A833-E1C7158F409CQ35138319-346E7FAF-35EF-4900-A8D4-B8625956DBE1Q35144075-FAF62508-125A-47F0-BCC1-9F870B651AB8Q35634259-085E0245-08DE-4245-A0A7-21D6C28B576DQ35777301-7EFFB654-527A-459B-B1D3-4E4FD7E26911Q35782919-00598845-CE51-44EC-AAA1-9C1A8BFD6A28Q35790849-177480D9-3AC1-47C8-B35D-A9BCBEF05D8AQ35989404-F13B1654-5D6F-4288-B88B-E9E28A77A7B0Q35994891-CEF58C2B-87D0-4AF8-87C5-0B9C9C479BF8Q36359510-4E672056-4582-4094-836D-5C4FA5E51347Q36382731-0CC6FC2B-B719-45C4-8BC5-D79585E85A43Q36607055-B547ACF3-AEFA-4976-AF7E-B15D1C5AE159Q37293838-4D918172-3A2D-4565-B1DA-2AAAE8E9FEF6Q37351050-33E2BEBC-1004-4825-AAD4-6F14ADEE0C44Q37619388-07F33AE9-D30F-41A8-956E-51840494EF32Q37747344-2228BA01-EBFC-491A-8620-05B4A50A0700Q39042983-77783D7E-8D3D-4E39-A384-E46149DCFC87Q39960680-5466B99C-2876-47D5-BC24-0BD1EB779175Q40410872-9A243C37-842A-4B76-8FF6-A99A0DCF7D79Q40449095-A04E13CA-3118-4DA3-BE00-640FB1FBA4FFQ40454403-6CFBF600-5398-4A01-ABF9-0E019621228BQ40606676-8F3C1816-6D09-42B2-8321-4C179D779507Q44331677-E12670A7-FBD7-464E-A09E-66C3E46B1F18Q51041845-7A4F557B-5DAD-4A49-A87B-5CD6BC57562DQ54580979-9B34C9CE-77D2-45ED-A7E4-B05D7A90C7D7Q55396812-4AECDD26-F85B-4DB9-AF02-70DC8055A2FE
P2860
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@ast
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@en
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@nl
type
label
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@ast
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@en
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@nl
prefLabel
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@ast
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@en
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@nl
P356
P1433
P1476
Cytokine control of developmental programs in normal hematopoiesis and leukemia.
@en
P2093
Joseph Lotem
P2888
P304
P356
10.1038/SJ.ONC.1205319
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1047924422